GRI Bio GRI
NASDAQ GRI
$1.67 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:49 PM EDT

GRI Bio (GRI) EPS (Basic) (2020 - 2026)

GRI Bio (GRI) posted quarterly EPS (Basic) of -$1.61 for Q1 2026, up 99.01% year-over-year from -$0.81 in Q1 2025, and up 99.3% quarter-over-quarter from -$230.38 in Q4 2025.

GRI Bio (GRI) EPS (Basic) (2020 - 2026) Analysis & Trends

GRI Bio's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$1.61 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 99.01% year-over-year to -$1.61; the TTM figure through Mar 2026 stood at -$24.97 (up 98.2% YoY), while the FY2025 annual figure was -$121.8, up 92.12% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$1.61, up from -$230.38 in the prior quarter.
  • The five-year high for EPS (Basic) was -$1.61 in Q1 2026, with the low at -$645375.0 in Q4 2022.
  • The 5-year median for EPS (Basic) is -$2847.7 (2024), against an average of -$98932.0.
  • The sharpest annual moves came in 2023 and 2026: EPS (Basic) plunged 292.46% in 2023, then soared 99.01% in 2026.
  • GRI Bio's EPS (Basic) stood at -$645375.0 in 2022, then soared by 65.81% to -$220626.7 in 2023, then jumped by 98.71% to -$2847.7 in 2024, then soared by 91.91% to -$230.38 in 2025, then soared by 99.3% to -$1.61 in 2026.
  • Business Quant data shows GRI's EPS (Basic) at -$1.61 in Q1 2026, -$230.38 in Q4 2025, and -$37.08 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 GRI Bio 3.01 Mn 3.01 Mn - -0.91

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.61
Dec 31, 2025 -230.38
Sep 30, 2025 -37.08
Jun 30, 2025 -36.79
Mar 31, 2025 -162.60
Dec 31, 2024 -2,847.67
Sep 30, 2024 -320.83
Jun 30, 2024 -2,348.60
Mar 31, 2024 -2,841.08
Dec 31, 2023 -220,626.67
Sep 30, 2023 -25,673.68
Jun 30, 2023 -105,964.29
Mar 31, 2023 -98,800.00
Dec 31, 2022 -645,375.00
Sep 30, 2022 -20,777.78
Jun 30, 2022 -27,000.00
Mar 31, 2022 -528,800.00
Dec 31, 2021 -2.02 Mn
Sep 30, 2021 -251,200.00
Jun 30, 2021 -462,000.00